Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion Genetic Engineering and Biotechnology News
Directly affected
- No company is named in this report.
Indirectly affected
- AMLP Alerian MLP ETF-1.7% 30d
Alerian MLP ETF: it holds pipeline operators. Linked by “pipeline” (pipelines) in this story.
- KMI Kinder Morgan
Kinder Morgan (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story.
- WMB The Williams Companies
The Williams Companies (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story.
- ET Energy Transfer-1.9% 30d
Energy Transfer (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story.
- PAA Plains All American Pipeline, L.P+5.7% 30d
Plains All American Pipeline, L.P (pipe lines (no natural gas)): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AMLPNo price data for this ticker | — | — | — | — | — | — | — |
| KMI | +7.75% | +3.81% | base | -1.98% | after close | after close | after close |
| WMB | +10.31% | +4.88% | base | -3.39% | after close | after close | after close |
| ET | +7.23% | +3.95% | base | -1.31% | after close | after close | after close |
| PAA | +6.68% | +1.72% | base | -2.00% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion Genetic Engineering and Biotechnology News
Price since this story was published: Alps Etf Tr (AMLP)
| Company | When | Move | Status |
|---|---|---|---|
| Energy Transfer (ET) | that day | -1.31% | still updating |
| Energy Transfer (ET) | three days earlier | +3.95% | final price |
| Energy Transfer (ET) | five days earlier | +7.23% | final price |
| Kinder Morgan (KMI) | that day | -1.98% | still updating |
| Kinder Morgan (KMI) | three days earlier | +3.81% | final price |
| Kinder Morgan (KMI) | five days earlier | +7.75% | final price |
| Plains All American Pipeline (PAA) | that day | -2.00% | still updating |
| Plains All American Pipeline (PAA) | three days earlier | +1.72% | final price |
| Plains All American Pipeline (PAA) | five days earlier | +6.68% | final price |
| Williams Companies (WMB) | that day | -3.39% | still updating |
| Williams Companies (WMB) | three days earlier | +4.88% | final price |
| Williams Companies (WMB) | five days earlier | +10.31% | final price |
Congressional trades in Alps Etf Tr (AMLP) around 5 Nov 2026
- Sen. Alan Armstrong sold Williams Companies (WMB) (jointly held), worth $250,001 - $500,000 on 8 Sep 2026. That is 58 days before publication. Filed 22 Oct 2026. View the filing.
- Sen. Alan Armstrong bought Williams Companies (WMB) (jointly held), worth $15,001 - $50,000 on 20 Aug 2026. That is 77 days before publication. Filed 17 Sep 2026. View the filing.
- Sen. Alan Armstrong bought Williams Companies (WMB) (jointly held), worth $1,001 - $15,000 on 19 Aug 2026. That is 78 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Alps Etf Tr (AMLP) on one side of this energy story
Companies mentioned with this story
- AMLP Alps Etf Tr
In “Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion,” Alps Etf Tr (AMLP) is linked, with no stored direction, medium confidence. Reason on file: Alerian MLP ETF: it holds pipeline operators. Linked by “pipeline” (pipelines) in this story
- KMI Kinder Morgan
For “Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion,” Kinder Morgan (KMI) is linked, with no stored direction, medium confidence. Reason on file: Kinder Morgan (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story
- WMB Williams Companies
Williams Companies (WMB) is linked, with no stored direction, medium confidence in the 5 Nov 2026 story “Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion.” Reason on file: The Williams Companies (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story
- ET Energy Transfer
In “Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion,” Energy Transfer (ET) is linked, with no stored direction, medium confidence. Reason on file: Energy Transfer (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story
- PAA Plains All American Pipeline
In “Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion,” Plains All American Pipeline (PAA) is linked, with no stored direction, medium confidence. Reason on file: Plains All American Pipeline, L.P (pipe lines (no natural gas)): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story
How energy news reaches Alps Etf Tr (AMLP)
“Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion” (5 Nov 2026) reaches Alps Etf Tr (AMLP) through Energy.
For Alps Etf Tr (AMLP), the reason on file says Alerian MLP ETF: it holds pipeline operators. Linked by “pipeline” (pipelines) in this story
Kinder Morgan (KMI) is here too. Its reason reads: Kinder Morgan (natural gas transmission): pipeline operators earn fees on the oil and gas they move. Linked by “pipeline” (pipelines) in this story
The price range for Alps Etf Tr (AMLP), and the dates in the story
AMLP traded between 51.55 and 54.20 across 20 sessions. The latest close on file is 52.75. KMI traded between 31.12 and 32.43 across 3 sessions. The latest close on file is 32.27. WMB traded between 66.31 and 74.30 across 3 sessions. The latest close on file is 67.88.
How strong the case is around Alps Etf Tr (AMLP)
40 out of 100Price not final
“Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline Expansion” scores 40 out of 100. The score uses 1 sources, and 5 linked companies. The price is not final yet.